(R)-N-(7-(1-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)-4-deuteropiperidin-4-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)-4(1-(2-fluorophenylthio)-4-(4-methylpiperazin-1-yl)butan-2-ylamino)-3-(triftuoromethylsulfonyl)benzenesulfonamide | 1274803-90-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: (R)-N-(7-(1-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)-4-deuteropiperidin-4-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)-4(1-(2-fluorophenylthio)-4-(4-methylpiperazin-1-yl)butan-2-ylamino)-3-(triftuoromethylsulfonyl)benzenesulfonamide
• 英文别名: N-[7-[1-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]-4-deuteriopiperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-1-(2-fluorophenyl)sulfanyl-4-(4-methylpiperazin-1-yl)butan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide
• CAS: 1274803-90-5
• 化学式: C₄₉H₆₁ClF₄N₈O₄S₃
• 分子量: 1034.71
• InChiKey: BFVYSLPKFAJRAU-ABFLZPMDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.2
• 重原子数：
  69
• 可旋转键数：
  16
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.51
• 拓扑面积：
  173
• 氢给体数：
  2
• 氢受体数：
  17

文献信息

• [EN] SULFONAMIDES AS INHIBITORS OF BCL-2 FAMILY PROTEINS FOR THE TREATMENT OF CANCER<br/>[FR] SULFAMIDES UTILISÉS COMME INHIBITEURS DES PROTÉINES DE LA FAMILLE DE BCL-2 DANS LE TRAITEMENT DU CANCER
  申请人：NOVARTIS AG

  公开号：WO2011029842A1

  公开（公告）日：2011-03-17

  The present invention includes novel compound and methods of treating a disease or disorder by antagonizing Bcl-2 family proteins, particularly compounds of Formula (I) or pharmaceutically acceptable salt thereof, as well as methods of treating a disease, disorder, or syndrome associated with Bcl-2 inhibition, particularly hyperproliferative diseases. The present invention also includes pharmaceutical compositions including compounds of formula (I) and pharmaceutically acceptable salts thereof.

  本发明涉及一种新型化合物和通过拮抗Bcl-2家族蛋白治疗疾病或紊乱的方法，特别是公式(I)的化合物或其药用盐，以及治疗与Bcl-2抑制相关的疾病、紊乱或综合征的方法，特别是高增殖性疾病。本发明还包括包括公式(I)的化合物和其药用盐的药物组合物。
• SULFONAMIDE COMPOUNDS
  申请人：Miller-Moslin Karen

  公开号：US20120165298A1

  公开（公告）日：2012-06-28

  The present invention includes novel compound and methods of treating a disease or disorder by antagonizing Bcl-2 family proteins, particularly compounds of formula (I): or pharmaceutically acceptable salt thereof, as well as methods of treating a disease, disorder, or syndrome associated with Bcl-2 inhibition, particularly hyperproliferative diseases. The present invention also includes pharmaceutical compositions including compounds of formula I and pharmaceutically acceptable salts thereof.

  本发明涉及一种新型化合物和通过拮抗Bcl-2家族蛋白治疗疾病或障碍的方法，特别是公式(I)的化合物或其药学上可接受的盐，以及治疗与Bcl-2抑制相关的疾病、障碍或综合症的方法，特别是过度增殖性疾病。本发明还包括包含公式I的化合物和其药学上可接受的盐的制药组合物。
• SULFONAMIDES AS INHIBITORS OF BCL-2 FAMILY PROTEINS FOR THE TREATMENT OF CANCER
  申请人：Novartis AG

  公开号：EP2475661A1

  公开（公告）日：2012-07-18
• US8809352B2
  申请人：——

  公开号：US8809352B2

  公开（公告）日：2014-08-19